secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001104659-22-071874
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech shareholders re-elect directors, approve auditor and compensation at AGM
--------------------------------------------------------------------------------

- Re-elected Pierre A. Morgon as director with 15,871,982 for, 1,050 against, 763 withheld.
- Re-elected Joseph C.F. Scheeren as director with 15,872,082 for, 1,598 against, 115 withheld.
- Appointed PricewaterhouseCoopers LLP as auditors for FY2022 with 15,873,184 for, 601 against.
- Approved directors' remuneration policy with 15,871,281 for, 2,404 against, 110 withheld.
- Received advisory approval of remuneration report with 15,866,826 for, 1,273 against, 5,696 withheld.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922071874/0001104659-22-071874-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922071874/tm2218504d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-071874

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer